Evidence map›Paper›PMID 35040097›Full record

ReviewCerebellum (London, England)2023

The Cerebellum in Niemann-Pick C1 Disease: Mouse Versus Man.

Maria Teresa Fiorenza, Piergiorgio La Rosa, Sonia Canterini, Robert P Erickson

Open access · greenAbstract readReview
In one paragraph

Review in Cerebellum (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Endo-lysosomal dysfunction and neuronal-glial crosstalk in Niemann-Pick type C disease.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Maria Teresa FiorenzaDivision of Neuroscience, Department of Psychology, University La Sapienza, Rome, Italy. mariateresa.fiorenza@uniroma1.it.ORCID http://orcid.org/0000-0002-5079-4019
Piergiorgio La RosaDivision of Neuroscience, Department of Psychology, University La Sapienza, Rome, Italy.
Sonia CanteriniDivision of Neuroscience, Department of Psychology, University La Sapienza, Rome, Italy.
Robert P EricksonDepartment of Pediatrics, University of Arizona School of Medicine, Tucson, AZ, 85724-5073, USA. rpe@arizona.edu.
Sapienza University of Rome · ITFondazione Santa Lucia · ITUniversity of Arizona · US

Funding

Fondazione Telethon GSP20006_Covid050Sapienza Università di Roma PH120172B92B8494
6 · The paper itself

Abstract

Selective neuronal vulnerability is common to most degenerative disorders, including Niemann-Pick C (NPC), a rare genetic disease with altered intracellular trafficking of cholesterol. Purkinje cell dysfunction and loss are responsible for cerebellar ataxia, which is among the prevailing neurological signs of the NPC disease. In this review, we focus on some questions that are still unresolved. First, we frame the cerebellar vulnerability in the context of the extended postnatal time length by which the development of this structure is completed in mammals. In line with this thought, the much later development of cerebellar symptoms in humans is due to the later development and/or maturation of the cerebellum. Hence, the occurrence of developmental events under a protracted condition of defective intracellular cholesterol mobilization hits the functional maturation of the various cell types generating the ground of increased vulnerability. This is particularly consistent with the high cholesterol demand required for cell proliferation, migration, differentiation, and synapse formation/remodeling. Other major questions we address are why the progression of Purkinje cells loss is always from the anterior to the posterior lobes and why cerebellar defects persist in the mouse model even when genetic manipulations can lead to nearly normal survival.

Indexed as

Niemann-Pick Disease, Type CAnimalsCerebellumCholesterolHumansMaleMammalsMiceNeuronsPurkinje CellsCholesterolCholesterolDevelopmentLysosomal storage diseaseNeuronal differentiation

Identifiers

PMID35040097
PMCPMC7617266
OpenAlexW4205442392

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.